{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T12:00:45Z","timestamp":1784116845783,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Shanghai Municipal Commission of Health and Family Planning","award":["ZY3-LCPT-1-1010"],"award-info":[{"award-number":["ZY3-LCPT-1-1010"]}]},{"name":"the Shanghai Municipal Commission of Health and Family Planning","award":["20174Y0038"],"award-info":[{"award-number":["20174Y0038"]}]},{"name":"the Science and Technology Commission of Shanghai Municipal","award":["17ZR1428100"],"award-info":[{"award-number":["17ZR1428100"]}]},{"name":"the Youth Science and Technology Talent Yang-fan Project of Shanghai","award":["17YF1417800"],"award-info":[{"award-number":["17YF1417800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anxiety disorders are the most prevalent class of lifetime disorders in China, and generalized anxiety disorder (GAD) is one of the most common but frequently overlooked anxiety disorders. Conventional pharmacological treatments for GAD have varying degrees of side effects, dependency, and\/or withdrawal syndromes. Traditional Chinese medicine (TCM) is considered a valuable therapeutic option for anxiety disorders and a potentially effective technique to reduce the side effects associated with antipsychotic drugs. This trial aimed to evaluate the clinical efficacy and safety of Antianxiety Granule, a granular Chinese medicine compound, for treatment of GAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/design<\/jats:title>\n                    <jats:p>The current work is a multicentre, randomized, double-blind, placebo-controlled, parallel-group clinical trial with a 6-week treatment schedule. The study consists of three periods: a 1\u20137-day screening period, a 6-week primary treatment period, and a 1-week follow-up period. Follow-up assessments will be conducted 1 week after the last visit with a face-to-face interview or by telephone. The clinical efficacy of Antianxiety Granule for the treatment of GAD will be evaluated by examining the change in the Hamilton anxiety scale (HAMA) score, state-trait anxiety inventory (STAI) score, and TCM symptom scale in patients with GAD who receive daily TCM treatment. Moreover, an intention-to-treat (ITT) analysis will also be used in this randomized controlled trial (RCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our study is a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the safety and efficacy of Antianxiety Granule for the treatment of GAD. The results of this trial will provide valuable clinical evidence for the treatment of GAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Chinese Clinical Trial Registry,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showproj.aspx?proj=27210\">ChiCTR1800016039<\/jats:ext-link>\n                      . Registered on 8 May 2018.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-020-4057-1","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T10:03:11Z","timestamp":1579773791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhongwei","family":"Sha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunchun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5359-758X","authenticated-orcid":false,"given":"Jian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"issue":"10053","key":"4057_CR1","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"T Vos","year":"2016","unstructured":"Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1545\u2013602.","journal-title":"Lancet"},{"issue":"3","key":"4057_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/da.22711","volume":"35","author":"J Alonso","year":"2018","unstructured":"Alonso J, Liu Z, Evans-Lacko S, Sadikova E, Sampson N, Chatterji S, et al. Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries. Depress Anxiety. 2018;35(3):195\u2013208.","journal-title":"Depress Anxiety"},{"key":"4057_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.janxdis.2018.05.003","volume":"56","author":"GJG Asmundson","year":"2018","unstructured":"Asmundson GJG, Asmundson AJN. Are anxiety disorders publications continuing on a trajectory of growth? A look at Boschen\u2019s (2008) predictions and beyond. J Anxiety Disord. 2018 May;56:1\u20134.","journal-title":"J Anxiety Disord"},{"issue":"5","key":"4057_CR4","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/jamapsychiatry.2017.0056","volume":"74","author":"AM Ruscio","year":"2017","unstructured":"Ruscio AM, Hallion LS, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade LH, et al. Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry. 2017;74(5):465\u201375.","journal-title":"JAMA Psychiatry"},{"issue":"21","key":"4057_CR5","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMcp1502514","volume":"373","author":"MB Stein","year":"2015","unstructured":"Stein MB, Sareen J. Clinical practice. Generalized anxiety disorder. N Engl J Med. 2015;373(21):2059\u201368.","journal-title":"N Engl J Med"},{"key":"4057_CR6","unstructured":"Andrews Dr G, Darlinghurst Dr G, et al. Mental and behavioural disorders (including disorders of psychological development). In: Tenth revision of the International classification of diseases. In: F41.1 Generalized anxiety disorder, Geneva: World Health Organization; January 20,2017. p.95\u201397."},{"key":"4057_CR7","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/nrdp.2017.24","volume":"3","author":"MG Craske","year":"2017","unstructured":"Craske MG, Stein MB, Lim CCW, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J, Andrade LH, et al. Anxiety disorders. Nat Rev Dis Primers. 2017;3:17024.","journal-title":"Nat Rev Dis Primers"},{"issue":"10173","key":"4057_CR8","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0140-6736(18)31793-8","volume":"393","author":"A Slee","year":"2019","unstructured":"Slee A, Nazareth I, Bondaronek P, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019;393(10173):768\u201377.","journal-title":"Lancet"},{"issue":"6\u20137","key":"4057_CR9","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/jpm.12314","volume":"23","author":"NJ Stomski","year":"2016","unstructured":"Stomski NJ, Morrison P, Meehan T. Mental health nurses' views about. antipsychotic medication side effects. J Psychiatr Ment Health Nurs. 2016;23(6\u20137):369\u201377.","journal-title":"J Psychiatr Ment Health Nurs"},{"key":"4057_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1471-244X-12-20","volume":"12","author":"M Dibonaventura","year":"2012","unstructured":"Dibonaventura M, Gabriel S, Dupclay L, Gupta S, Kim E. A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia. BMC Psychiatry. 2012;12:20.","journal-title":"BMC Psychiatry"},{"issue":"13","key":"4057_CR11","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1017\/S0033291717000903","volume":"47","author":"T Wykes","year":"2017","unstructured":"Wykes T, Evans J, Paton C, et al. What side effects are problematic for patients prescribed antipsychotic medication? The Maudsley Side Effects (MSE) measure for antipsychotic medication. Psychol Med. 2017;47(13):2369\u201378.","journal-title":"Psychol Med"},{"issue":"2","key":"4057_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/jpm.12288","volume":"23","author":"R Gray","year":"2016","unstructured":"Gray R, Deane K. What is it like to take antipsychotic medication? A qualitative study of patients with first-episode psychosis. J Psychiatr Ment Health Nurs. 2016;23(2):108\u201315.","journal-title":"J Psychiatr Ment Health Nurs"},{"issue":"8","key":"4057_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1177\/070674371105600809","volume":"56","author":"S Salzer","year":"2011","unstructured":"Salzer S, Winkelbach C, Leweke F, et al. Long-term effects of short-term psychodynamic psychotherapy and cognitive-behavioural therapy in generalized anxiety disorder: 12-month follow-up. Can J Psychiatr. 2011;56(8):503\u20138.","journal-title":"Can J Psychiatr"},{"key":"4057_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pnpbp.2013.04.016","volume":"45","author":"CA Bartley","year":"2013","unstructured":"Bartley CA, Hay M, Bloch MH. Meta-analysis: aerobic exercise for the treatment of anxiety disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2013;45:34\u20139.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"8","key":"4057_CR15","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jagp.2016.03.008","volume":"24","author":"MA Stanley","year":"2016","unstructured":"Stanley MA, Wilson N, Shrestha S, Amspoker AB, Armento M, Cummings JP, et al. Calmer life: a culturally tailored intervention for anxiety in underserved older adults. Am J Geriatr Psychiatry. 2016;24(8):648\u201358.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"6","key":"4057_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000339371","volume":"81","author":"G Andersson","year":"2012","unstructured":"Andersson G, Paxling B, Roch-Norlund P, Ostman G, Norgren A, Almlov J, et al. Internet-based psychodynamic versus cognitive behavioral guided self-help for generalized anxiety disorder: a randomized controlled trial. Psychother Psychosom. 2012;81(6):344\u201355.","journal-title":"Psychother Psychosom"},{"issue":"14","key":"4057_CR17","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1016\/j.phymed.2016.10.013","volume":"23","author":"JR Keefe","year":"2016","unstructured":"Keefe JR, Mao JJ, Soeller I, Li QS, Amsterdam JD. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder. Phytomedicine. 2016;23(14):1699\u2013705.","journal-title":"Phytomedicine"},{"issue":"4","key":"4057_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s40263-013-0059-9","volume":"27","author":"J Sarris","year":"2013","unstructured":"Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. CNS Drugs. 2013;27(4):301\u201319.","journal-title":"CNS Drugs"},{"issue":"1","key":"4057_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50\u20135.","journal-title":"Br J Med Psychol"},{"issue":"7\u20138","key":"4057_CR20","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0005-7967(98)00023-0","volume":"36","author":"PJ Bieling","year":"1998","unstructured":"Bieling PJ, Antony MM, Swinson RP. The State-Trait Anxiety Inventory, Trait version: structure and content re-examined. Behav Res Ther. 1998;36(7\u20138):777\u201388.","journal-title":"Behav Res Ther"},{"issue":"3","key":"4057_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1207\/s15327906mbr1003_6","volume":"10","author":"E Gaudry","year":"1975","unstructured":"Gaudry E, Vagg P, Spielberger CD. Validation of the State-Trait distinction in anxiety research. Multivar Behav Res. 1975;10(3):331\u201341.","journal-title":"Multivar Behav Res"},{"issue":"3","key":"4057_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","volume":"6","author":"H Yueqin","year":"2019","unstructured":"Yueqin H, Yu W, Wang H, et al. Prevalence of mental disorders in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2019;6(3):211\u201324.","journal-title":"Lancet Psychiatry"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-4057-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T19:35:31Z","timestamp":1611257731000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-4057-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4057"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-4057-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.11718\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.11718\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The central ethical approval was obtained from the Ethics Committee of the Shanghai Municipal Hospital of Traditional Chinese Medicine (approval no. 2017SHL-KY-14) and we will not begin recruiting at other centres in the trial until local ethical approval has been obtained. All participants will provide written informed consent before enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}